Results 281 to 290 of about 96,828 (293)

Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

Nature Reviews Gastroenterology and Hepatology, 2016
Jesus M Banales, Vincenzo Cardinale, Guido Carpino   +2 more
exaly  

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Lancet Oncology, The, 2020
Ghassan K Abou-Alfa, Antoine Hollebecque, Davide Melisi   +2 more
exaly  

Clinical diagnosis and staging of cholangiocarcinoma

Nature Reviews Gastroenterology and Hepatology, 2011
Mina Komuta, Tania A Roskams, Gregory J Gores   +2 more
exaly  

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Lancet Oncology, The, 2020
Ghassan K Abou-Alfa, Teresa Macarulla, Robin Kate Kelley   +2 more
exaly  

HILAR CHOLANGIOCARCINOMA

Australian and New Zealand Journal of Surgery, 1989
A, Czerniak, L H, Blumgart
openaire   +2 more sources

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma

Cancer Cell, 2017
Jittiporn Chaisaingmongkol, Siritida Rabibhadana, Yotsawat Pomyen   +2 more
exaly  

Liver transplantation for intrahepatic cholangiocarcinoma

Lancet, The, 2014
Tetsuji Fujita
exaly  

The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma

Nature Reviews Gastroenterology and Hepatology, 2011
Alphonse Sirica
exaly  

Cholangiocarcinoma

2020
Nicholas Latchana, Sean Cleary, Carol-anne E. Moulton   +2 more
openaire   +1 more source

Cholangiocarcinoma

2023
openaire   +1 more source